Accueil > Actualité
Actualite financiere : Actualite bourse

Roche: joins forces with US drugmaker for COVID treatment

( - Roche said on Thursday that it will team up with US biopharmaceutical firm Atea to develop a potential oral treatment for COVID-19 patients.

The two companies said they are joining forces to develop, manufacture and distribute Atea's investigational antiviral AT-527, which blocks the RNA polymerase enzyme needed for viral replication.

The drug is currently being studied in a phase 2 clinical trial for hospitalised patients with moderate COVID-19, with a phase 3 trial expected to start in early 2021 in outpatients.

Copyright (c) 2020 All rights reserved.




Qui sommes-nous ? | Nous contacter | FAQ | Mentions légales | RSS | © Copyright 2007 Cercle Finance. Tous droits réservés.
Indices et cours différés d’au moins 15 mn | Cotations boursières fournies par ABC Bourse.